China Pharma Holdings Inc (CPHI) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NYSE MKT. Price $0.72 (+1.34%), Market cap $0.03B, 52-week low–high $0.52 ~ $2.22.
China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Dies
Financial statements, price targets, institutional (13F) holdings and related news for China Pharma Holdings Inc are updated in real time on BlackAll Trade.
China Pharma Holdings Inc trades at $0.72 (+1.34%). Real-time quotes and charts are available on BlackAll Trade.
China Pharma Holdings Inc has a market cap of about $0.03B.
China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injecta